News
This cash-strapped company is shifting from its roots in cancer drug development to focus on cosmetic treatments.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback